ATHENS MEDICAL SOCIETY

ATTIKON University General Hospital, ATHENS

Presentations of Athena International Conference 2017

Tuesday 28-11-2017

       

08.55-09.00 Welcome and introductions

G. Dimopoulos(Greece)

(view presentation)

09.00-11.00

I. Infections in the ICU : what is newer?
Chairs :A Armaganidis (Greece) – H. Giamarellou (Greece) – A. Komnos (Greece)


09.00-09.15 Intratracheal antibiotics administration

J. Chastre (France)

(view presentation)
09.15-09.30 New data on aerolized antibiotics

M. Kollef (USA)

(view presentation)
09.30-09.45 VAT: something different?

S. Nseir (France)

(view presentation)
09.45-10.00 Any role for β-lactam in XDR/PDR pathogens?

G. Daikos (Greece)

10.00-10.15 Individualized antibiotic strategies

F. Taccone (Belgium)

(view presentation)
10.15-10.30 The role of viral pneumonia in the ICU

M. Kollef (USA)

(view presentation)
10.30-11.00 Discussion

11.00-12.00

II. Infections in ICU: What is newer?
Chairs: P. Gargalianos (Greece) – V. Koulouras (Greece) – E. Gkeka (Greece)

11.00-11.15 Colistin versus Polymyxin B

D. Nicolau (USA)

(view presentation)
11.15-11.30 Treatment of PDR infections: do we have a hope?

H. Giamarellou (Greece)

(view presentation)
11.30-11.45 Optimizing antifungal dosing regimens

J. Meletiadis (Greece)

(view presentation)
11.45-12.00 Discussion

     

12.00-13.00

Break

     

13.00-15.00

III. Infections in ICU: What is newer?
Chairs: L. Mouloudi (Greece) – D. Kofteridis (Greece) – P. Maliotakis (Greece)

13.00-13.15 Infections in refugees

J.F. Timsit (France)

(view presentation)
13.15-13.30 Infections in patients under monoclonal antibodies

M. Akova (Turkey)

13.30-13.45 Pulmonary hypertension and infections

S. Orfanos (Greece)

13.45-14.00 Silver-coated endotracheal tubes

M. Antonelli (Italy)

(view presentation)
14.00-14.15 VAP in COPD patients

I. Martin-Loeches (Ireland)

(view presentation)
14.15-14.30 Klebsiella KPC: risk factors

M. Antonelli (Italy)

(view presentation)
14.30-15.00 Discussion

       

15.00-15.30

Break

    

15.30-17.30

IV. Infections in ICU: What is newer?
Chairs: S. Pournaras (Greece) - A. Koutsoukou (Greece) - S. Asimakopoulos (Greece)


         

15.30-15.45 MRSA BSIs

P. Montravers (France)

(view presentation)
15.45-16.00 MRSA VAP

J. Chastre (France)

(view presentation)
16.00-16.15 Infections due to VISA pathogens

JR. Zahar (France)

(view presentation)
16.15-16.30 Pneumonococcal vaccination

G Poulakou (Greece)

16.30-16.45 Abdominal sepsis (Antiinfectives in multiresistance era)

M. Bassetti (Italy)

16.45-17.00 Carbapenemases: testing and screening

D. Nicolau (USA)

(view presentation)
17.00-17.30 Discussion

         

17.30-18.00

State of the art lecture
Chairs: G. Baltopoulos (Greece) – E. Antoniadou (Greece)

Esmolol in the ICU

J.L. Vincent (Belgium)

Break

       

18.30-20.00

Satellite Symposium sponsored by PFIZER
Title: The role of Ceftazidime–Avibactam in the optimization of treatment strategies for patients with difficult to treat Gram (-) infections
Chairs:H. Giamarellou (Greece) – I. Pnevmatikos (Greece)

         

18.30-18.50 Difficult to treat Gram(-) infections: epidemiology and treatment strategies

G. Daikos (Greece)

18.50-19.10 Evidence-based review of the pharmacology of Ceftazidime–Avibactam combination

D. Nicolau (USA)

(view presentation)
19.10-19.30 Ceftazidime–Avibactam combination: clinical trial data

M. Antonelli (Italy)

(view presentation)
19.30-19.50 Latest evidence and real-world data on Ceftazidime–Avibactam - What patient? What Infection?

M. Bassetti (Italy)


19.50-20.00 Discussion

Wednesday 29-11-2017

       

09.00-11.00

The role of PK/PD of antibiotics in critically ill
Chairs: M. Marangos (Greece) - E. Zakynthinos (Greece) – G. Vlachogianni (Greece)

09.00-09.15 Augmented Renal Clearance and Drug Dosing

J. Lipman (Australia)

(view presentation)
09.15-09.30 Plasma protein binding changes of antibiotics

F.S. Taccone (Belgium)

(view presentation)
09.30-09.45 Antibiotics: Continuous infusion

J. DeWaele (Belgium)

(view presentation)
09.45-10.00 The antibiotic dose and the obese ICU patient

P. Montravers (France)

(view presentation)
10.00-10.15 Antibiotics in elderly ICU patient

S. Nseir (France)

(view presentation)
10.15-10.30 Antibiotics during CRRTs

J. Lipman (Australia)

(view presentation)
10.30-11.00 Discussion

     

11.00-12.00

Satellite Symposium sponsored by ASTELLAS
Title: Candida infections in the ICU
Chairs: G. Daikos (Greece)

11.00-11.05 Introduction

G. Daikos (Greece)

11.05-11.45 Candida infections in the ICU

P. Pappas (USA)

(view presentation)
11.45-11.55 Discussion
11.55-12.00 Closing Remarks

A. Armaganidis (Greece)

     

12.00-12.45

New Sepsis definitions
Chairs: T. Vassilakopoulos (Greece) - C. Gogos (Greece)

12.00-12.15 The need for new sepsis definitions

J.L. Vincent (Belgium)

12.15-12.30 Validating the new sepsis definitions

E. Giamarellos (Greece)

(view presentation)
12.30-12.45 Discussion

     

12.45-14.00

Break.

     

14.00-16.00

Fungal infections
Chairs: I. Pnevmatikos (Greece) - N. Sipsas (Greece) – N. Kapravelos (Greece)

14.00-14.15 PK/PDs of antifungals

D. Nicolau (USA)

(view presentation)
14.15-14.30 Resistance to antifungals

P. Pappas (USA)

(view presentation)
14.30-14.45 Combination of antifungals

T. Calandra (Switzerland)

14.45-15.00 Candida infections in cirrhotic/transplanted patients

M. Bassetti (Italy)

15.00-15.15 The role of new azoles

O. Cornely (Germany)

15.15-15.30 The role of new echinocandins

P. Pappas (USA)

(view presentation)
15.30-16.00 Discussion

16.00-16.30

Break.

     


         

16.30-18.00

The Research Gate
Chairs: D. Georgopoulos (Greece) - A. Pefanis (Greece) – K. Arvaniti (Greece)

16.30-16.45 AbSeS study

Stijn Blot (Belgium)

(view presentation)
16.45-17.00 Diana study

Jan De Waele (Belgium)

(view presentation)
17.00-17.15 ENRIRI study

I. Martin-Loeches (Ireland)

(view presentation)
17.15-17.30 MDR/XDR/PDR : the pipeline of new antibiotics

M. Falagas (Greece)

17.30-17.45 Temocillin: a new weapon for KPC infections?

M. Akova (Turkey)

17.45-18.00 Discussion

     

18.00-18.30

Break.

     

18.30-19.30

Satellite Symposium sponsored by MSD New approaches and novel antibiotics for the management of cIAI & C UTI focusing on Resistant Pseudomonas and ESBLs producing Enterobacteriaceae
Chairs: C. Gogos

18.30-18.50 Understanding the importance of local institutional epidemiology in driving treatment choice for patients at risk of resistant gram negative infections

M Bassetti (Italy)

18.50-19.10 Informed Empiric Use of Novel Antibiotics for the Management of cIAI & cUTI looking at Resistant Pseudomonas and ESBLs producing Enterobacteriaceae

Jan deWaele (Belgium)

19.10-19.30 Q & A & Closing Remarks Chair

Thursday 30-11-2016

       

09.00-11.00

Prevention of infections
Chairs: A Tsakris (Greece) – G. Dalekos (Greece) – A. Karapanagiotou (Greece)

09.00-09.15 SSTIs sepsis (Surgery, antimicrobial therapy and more)

C.Eckmann (Germany)

(view presentation)
09.15-09.30 The endotracheal tube cuff: shape & material

S. Blot (Belgium)

(view presentation)
09.30-09.45 Antimicrobial surfaces

M. Niederman (USA)

(view presentation)
09.45-10.00 Diffuse peritonitis : The importance of source control

C. Eckmann (Germany)

(view presentation)
10.00-10.15 Catheter impregnation and CVC infections

J. Carnacho-Montero (Spain)

10.15-10.30 There is a role for antifungal prophylaxis in the ICU?

J.A. Paiva (Portugal)

(view presentation)
10.30-11.00 Discussion

     

11.00-11.30

State of the art lecture sponsored by NORMA HELLAS.
Chairs: G. Poulakou (Greece)

Old drugs for Staphylococcus infections

I. Gould (UK)

(view presentation)

     

11.30-12.30

Satellite Symposium sponsored by MSD Update on MRSA critical Infections
Title: Update on MRSA critical Infections
Chairs: G. Dalekos (Greece)

     

11.35-11.55 Do Gram positive infections still a major threat to patients and health care systems?

C.Eckmann (Germany)

(view presentation)
11.55-12.15 Contribution of new Antibiotics to today’s and tomorrow’s G+ infections challenges?
12.15-12.25 Panel Q & A - Chair
12.25-12.30 Closing Remarks - Chair

     

12.30-13.30

Break

     

13.00-15.00

Figthing the resistance in the ICU
Chairs: I. Tsangaris (Greece) - A. Skiada (Greece) – Th. Paraforou (Greece)

13.30-13.45 The modern concept of de-escalation in the ICU

J.F. Timsit (France)

(view presentation)
13.45-14.00 The use of gene transcriptomics as surrogate markers

E. Giamarellos (Greece)

(view presentation)
14.00-14.15 Microdialysis and antibiotics: the right doses

J. Lipman (Australia)

(view presentation)
14.15-14.30 The role of surveillance cultures

M. Niederman (USA)

(view presentation)
14.30-14.45 MRSA: decolonization in the ICU?

I. Gould (UK)

(view presentation)
14.45-15.00 Discussion

15.00-16.00

Advances in Infections in the ICU
Chairs: A. Kotanidou (Greece) - D. Matthaiou (Greece) – S. Anisoglou (Greece)

         

15.00-15.15 Colistin-Fosfomycin

J.A. Paiva (Portugal)

(view presentation)
15.15-15.30 New promising antibacterials

I. Gould (UK)

(view presentation)
15.30-15.45 The new long acting glycopeptides

J.R. Zahar (France)

15.45-16.00 Discussion
Copyright © 2019 ATHENA International Conference. Design by PlanTech